NFG
ATOS icon

Next Financial Group’s Atossa Therapeutics ATOS Stock Holding History

Next Financial Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
13
– – ﹤0.01% 2858
2021
Q3 		$1K Sell
13
-7
-35% -$407 ﹤0.01% 2571
2021
Q2 		$2K Buy
+20
New +$1.06K ﹤0.01% 2377

Other funds holding ATOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Next Financial Group's ATOS Position: Q4 2021 in Review

Next Financial Group held its Atossa Therapeutics (ATOS) position steady in Q4 2021 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

Next Financial Group first reported a position in ATOS in Q2 2021 and has held it in 3 quarters since. The position peaked at $2K in Q2 2021. 92 funds tracked by Wall St. Rank hold ATOS as of Q4 2021.

  • Next Financial Group held 13 shares of Atossa Therapeutics worth $0 as of Q4 2021.
  • Next Financial Group left its Atossa Therapeutics share count unchanged in Q4 2021.
  • Atossa Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2858 holding.
  • Next Financial Group first reported a position in Atossa Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • Next Financial Group's Atossa Therapeutics position peaked at $2K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.